Omega Therapeutics (OMGA) – Research Analysts' Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of Omega Therapeutics (NASDAQ: OMGA) recently: 5/24/2022 – Omega Therapeutics had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $7.00 to $4.00. They now have a “neutral” rating on the stock. 5/24/2022 – Omega Therapeutics was downgraded […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Blackrock ,United Kingdom General ,Piper Sandler ,Investment Holdings ,Omega Therapeutics Inc ,Goldman Sachs Group Inc ,Zacks Investment Research ,Blackrock Inc ,Vanguard Group Inc ,Omega Therapeutics ,Goldman Sachs Group ,Get Rating ,Nasdaq Omga ,Komga ,